Air pollution is now known to exacerbate existing cardiovascular disease and contribute to the development of the disease.

It is particularly true for outdoor particle pollution exposure. Air pollution, particularly fine particulate matter (PM2.5), has significant implications for cardiovascular health. PM2.5 consists of tiny particles less than 2.5 micrometers in diameter, which can penetrate deep into the lungs and enter the bloodstream and can increase the risk of cardiovascular events.

Individuals with existing cardiovascular diseases are especially vulnerable to the adverse effects of PM2.5. These particles can induce inflammation, oxidative stress, and endothelial dysfunction, exacerbating pre-existing conditions and potentially leading to acute health crises. Moreover, even short-term exposure to high levels of PM2.5 can trigger harmful cardiovascular events, emphasizing the urgent need for public health interventions.

We, Reliance MedLabs, want to put collective efforts to mitigate pollution and reduce the burden of heart disease through our preventative health diagnostic services.